Panel Discussions
Title Julie Kim, President of Plasma-Derived Therapies at Takeda
Covid 19 treatments progress from 8 leaders. Watch here. |
Dr. Nancy Whiting, EVP of Seattle Genetics
The impact of the life science industry. Watch here. |
Dr. Pearl Huang, CEO President of Cygnal Therapeutics
The Nervous System and Cancer. Watch here. |